These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 24227706

  • 1. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
    Mariño-Enríquez A, Hornick JL, Dal Cin P, Cibas ES, Qian X.
    Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
    [Abstract] [Full Text] [Related]

  • 2. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry.
    Kammerer-Jacquet SF, Thierry S, Cabillic F, Lannes M, Burtin F, Henno S, Dugay F, Bouzillé G, Rioux-Leclercq N, Belaud-Rotureau MA, Stock N.
    Hum Pathol; 2017 Jan; 59():34-40. PubMed ID: 27597521
    [Abstract] [Full Text] [Related]

  • 3. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A, Fletcher CD, Dal Cin P, Hornick JL.
    Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
    [Abstract] [Full Text] [Related]

  • 4. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S, Chibon F, Ouali M, Perot G, Decouvelaere AV, Robin YM, Larousserie F, Terrier P, Coindre JM, Neuville A.
    Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
    [Abstract] [Full Text] [Related]

  • 5. [Clinical value of fluorescence in situ hybridization with MDM2 and DDIT3 probe in diagnosis of liposarcoma].
    Wang W, Li X, Liu P, Dong Y.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr 18; 55(2):228-233. PubMed ID: 37042132
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
    Thway K, Flora R, Shah C, Olmos D, Fisher C.
    Am J Surg Pathol; 2012 Mar 18; 36(3):462-9. PubMed ID: 22301498
    [Abstract] [Full Text] [Related]

  • 7. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases.
    Sharma AE, Dickson M, Singer S, Hameed MR, Agaram NP.
    Mod Pathol; 2024 Jun 18; 37(6):100494. PubMed ID: 38621503
    [Abstract] [Full Text] [Related]

  • 8. Dedifferentiated liposarcoma with homologous lipoblastic differentiation: expanding the spectrum to include low-grade tumours.
    Liau JY, Lee JC, Wu CT, Kuo KT, Huang HY, Liang CW.
    Histopathology; 2013 Apr 18; 62(5):702-10. PubMed ID: 23425231
    [Abstract] [Full Text] [Related]

  • 9. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
    Italiano A, Bianchini L, Gjernes E, Keslair F, Ranchere-Vince D, Dumollard JM, Haudebourg J, Leroux A, Mainguené C, Terrier P, Chibon F, Coindre JM, Pedeutour F.
    Clin Cancer Res; 2009 Sep 15; 15(18):5696-703. PubMed ID: 19737942
    [Abstract] [Full Text] [Related]

  • 10. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
    Chung L, Lau SK, Jiang Z, Loera S, Bedel V, Ji J, Weiss LM, Chu PG.
    Am J Surg Pathol; 2009 Nov 15; 33(11):1594-600. PubMed ID: 19574885
    [Abstract] [Full Text] [Related]

  • 11. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
    Italiano A, Bianchini L, Keslair F, Bonnafous S, Cardot-Leccia N, Coindre JM, Dumollard JM, Hofman P, Leroux A, Mainguené C, Peyrottes I, Ranchere-Vince D, Terrier P, Tran A, Gual P, Pedeutour F.
    Int J Cancer; 2008 May 15; 122(10):2233-41. PubMed ID: 18214854
    [Abstract] [Full Text] [Related]

  • 12. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.
    Song MJ, Cho KJ, Lee JS, Song JS.
    Appl Immunohistochem Mol Morphol; 2017 May 15; 25(10):712-719. PubMed ID: 27028243
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic Utility and Limitations of Immunohistochemistry of p16, CDK4, and MDM2 and Automated Dual-color In Situ Hybridization of MDM2 for the Diagnosis of Challenging Cases of Dedifferentiated Liposarcoma.
    Kobayashi A, Sakuma T, Fujimoto M, Jimbo N, Hirose T.
    Appl Immunohistochem Mol Morphol; 2019 May 15; 27(10):758-763. PubMed ID: 31145104
    [Abstract] [Full Text] [Related]

  • 14. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
    Dantey K, Schoedel K, Yergiyev O, Bartlett D, Rao UNM.
    Hum Pathol; 2017 Aug 15; 66():86-92. PubMed ID: 28300575
    [Abstract] [Full Text] [Related]

  • 15. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
    Kuczkiewicz-Siemion O, Wiśniewski P, Dansonka-Mieszkowska A, Grabowska-Kierył M, Olszewska K, Goryń T, Prochorec-Sobieszek M, Rutkowski P, Szumera-Ciećkiewicz A.
    Pathol Res Pract; 2021 Sep 15; 225():153555. PubMed ID: 34325315
    [Abstract] [Full Text] [Related]

  • 16. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
    Binh MB, Sastre-Garau X, Guillou L, de Pinieux G, Terrier P, Lagacé R, Aurias A, Hostein I, Coindre JM.
    Am J Surg Pathol; 2005 Oct 15; 29(10):1340-7. PubMed ID: 16160477
    [Abstract] [Full Text] [Related]

  • 17. Liposarcoma of the pleural cavity.
    Kawai T, Nakashima H, Washimi K, Yokose T, Matsuo T, Nakayama M, Shinohara N, Kuroda H, Ishida K, Akiba J, Ishikawa M, Urabe S, Shiraishi J, Shiraishi T, Sakamoto A, Matsukuma S.
    Hum Pathol; 2023 Jun 15; 136():105-113. PubMed ID: 37023867
    [Abstract] [Full Text] [Related]

  • 18. Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours.
    Aleixo PB, Hartmann AA, Menezes IC, Meurer RT, Oliveira AM.
    J Clin Pathol; 2009 Dec 15; 62(12):1127-35. PubMed ID: 19946100
    [Abstract] [Full Text] [Related]

  • 19. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
    Coindre JM, Hostein I, Maire G, Derré J, Guillou L, Leroux A, Ghnassia JP, Collin F, Pedeutour F, Aurias A.
    J Pathol; 2004 Jul 15; 203(3):822-30. PubMed ID: 15221942
    [Abstract] [Full Text] [Related]

  • 20. Hibernoma Mimicking Atypical Lipomatous Tumor: 64 Cases of a Morphologically Distinct Subset.
    Al Hmada Y, Schaefer IM, Fletcher CDM.
    Am J Surg Pathol; 2018 Jul 15; 42(7):951-957. PubMed ID: 29629919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.